CD8A and hepatocellular carcinoma: As a result, COX2-mediated prostaglandin E2 (PGE2) boosted Tregs and PD-1+ CD8+ T cells by binding to PTGER4 (Prostaglandin E Receptor 4) on them, thereby contributing to HCC progression.